Palvella Therapeutics (PVLA) Gains from Investment Securities (2016 - 2024)
Historic Gains from Investment Securities for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to -$843000.0.
- Palvella Therapeutics' Gains from Investment Securities fell 453684.21% to -$843000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was -$869000.0, marking a year-over-year decrease of 52184.47%. This contributed to the annual value of $489283.0 for FY2023, which is 8408.98% down from last year.
- As of Q3 2024, Palvella Therapeutics' Gains from Investment Securities stood at -$843000.0, which was down 453684.21% from -$26000.0 recorded in Q2 2024.
- Palvella Therapeutics' 5-year Gains from Investment Securities high stood at $636000.0 for Q3 2020, and its period low was -$843000.0 during Q3 2024.
- Over the past 5 years, Palvella Therapeutics' median Gains from Investment Securities value was -$26000.0 (recorded in 2024), while the average stood at -$42368.4.
- In the last 5 years, Palvella Therapeutics' Gains from Investment Securities soared by 138250.0% in 2022 and then tumbled by 453684.21% in 2024.
- Palvella Therapeutics' Gains from Investment Securities (Quarter) stood at -$764000.0 in 2020, then soared by 107.33% to $56000.0 in 2021, then surged by 37.5% to $77000.0 in 2022, then plummeted by 106.49% to -$5000.0 in 2023, then tumbled by 16760.0% to -$843000.0 in 2024.
- Its last three reported values are -$843000.0 in Q3 2024, -$26000.0 for Q2 2024, and $5000.0 during Q1 2024.